MacroGenics
MGNX
#9393
Rank
ยฃ65.05 M
Marketcap
ยฃ1.03
Share price
-0.72%
Change (1 day)
-61.29%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.15 Billion

According to MacroGenics's latest financial reports the company's total liabilities are ยฃ0.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.11 B1.38%
2023-12-31ยฃ0.11 B0%
2022-12-31ยฃ0.11 B61.55%
2021-12-31ยฃ70.84 M16.54%
2020-12-31ยฃ60.78 M-2.64%
2019-12-31ยฃ62.43 M-11.2%
2018-12-31ยฃ70.31 M27.31%
2017-12-31ยฃ55.23 M60.31%
2016-12-31ยฃ34.45 M11.16%
2015-12-31ยฃ30.99 M-8.26%
2014-12-31ยฃ33.78 M18.91%
2013-12-31ยฃ28.41 M-25.91%
2012-12-31ยฃ38.34 M-25.65%
2011-12-31ยฃ51.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Xencor
XNCR
ยฃ0.18 B 19.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 56,650.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.27 B 38,002.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ27.83 B 18,096.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ60.44 B 39,417.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ68.37 B 44,601.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.76 B 38,321.79%๐Ÿ‡บ๐Ÿ‡ธ USA